Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
ZHEJIANG UNIVERSITY currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action across the entire portfolio. This single pending action is handled by 1 distinct examiner, indicating a highly concentrated prosecution effort at this stage.
The prosecution activity is limited to 1 distinct art unit, which suggests a very specific technical focus for the university's current filings. BOECKELMAN, JACOB A is identified as the busiest examiner for the company. This individual is responsible for 1 busiest examiner pending office action. The alignment between the total pending workload and the responsibility of this specific examiner suggests that all current patent office interactions are centralized.
Practitioners should note that the portfolio's current activity is confined to a single point of contact. This concentration in the Biotechnology & Pharmaceuticals sector allows for a very specific prosecution strategy. With only one person reviewing the university's work, the immediate legal focus is narrow. The presence of the single art unit further confirms that the university's current patent efforts are not spread across different administrative divisions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18344828 | METHOD FOR PREPARING A FEEDING INSTANT ASTRAGALUS POLYSACCHARIDE POWDER AND APPLICATION THEREOF | BOECKELMAN, JACOB A | 26d |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18344828 | METHOD FOR PREPARING A FEEDING INSTANT ASTRAGALUS POLYSACCHARIDE POWDER AND APPLICATION THEREOF | BOECKELMAN, JACOB A | 1655 | §103 | Final Rejection | 26d | Pending | Jun 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZHEJIANG UNIVERSITY has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacob A Boeckelman has the most, with 1 of ZHEJIANG UNIVERSITY's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
